Skip to content
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Menu
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
Read more about the article Health Canada Continues to Support Psychedelic Medicine

Health Canada Continues to Support Psychedelic Medicine

  • Post author:Olly PP
  • Post published:May 24, 2022
  • Post category:News

Continue ReadingHealth Canada Continues to Support Psychedelic Medicine
Read more about the article Burnaby company granted Health Canada licence to produce ‘magic mushroom medicine’

Burnaby company granted Health Canada licence to produce ‘magic mushroom medicine’

  • Post author:Olly PP
  • Post published:May 20, 2022
  • Post category:News

Continue ReadingBurnaby company granted Health Canada licence to produce ‘magic mushroom medicine’
Read more about the article The Mission to Make Psilocybin Available to UK Cancer Patients

The Mission to Make Psilocybin Available to UK Cancer Patients

  • Post author:Olly PP
  • Post published:April 25, 2022
  • Post category:News

Continue ReadingThe Mission to Make Psilocybin Available to UK Cancer Patients
Read more about the article Is the UK Becoming a Global Center for Psychedelic Medicine?

Is the UK Becoming a Global Center for Psychedelic Medicine?

  • Post author:Olly PP
  • Post published:March 15, 2022
  • Post category:News

Continue ReadingIs the UK Becoming a Global Center for Psychedelic Medicine?
Read more about the article Using Real-World Evidence to Accelerate Psychedelic Drug Development

Using Real-World Evidence to Accelerate Psychedelic Drug Development

  • Post author:Olly PP
  • Post published:February 9, 2022
  • Post category:News

Continue ReadingUsing Real-World Evidence to Accelerate Psychedelic Drug Development
Read more about the article Albert Labs receives conditional approval for CSE listing

Albert Labs receives conditional approval for CSE listing

  • Post author:Olly PP
  • Post published:November 30, 2021
  • Post category:News

Continue ReadingAlbert Labs receives conditional approval for CSE listing
Read more about the article Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker

Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker

  • Post author:Olly PP
  • Post published:November 29, 2021
  • Post category:News

Continue ReadingAnother Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
Read more about the article ViewPoints Interview: Albert Labs’ Dr. Malcolm Barratt-Johnson Shares Insights on Psychedelic-Assisted Therapies

ViewPoints Interview: Albert Labs’ Dr. Malcolm Barratt-Johnson Shares Insights on Psychedelic-Assisted Therapies

  • Post author:barneyneal96
  • Post published:June 19, 2021
  • Post category:News

Continue ReadingViewPoints Interview: Albert Labs’ Dr. Malcolm Barratt-Johnson Shares Insights on Psychedelic-Assisted Therapies
Read more about the article Drug developer uses RWE to research psychedelic therapies

Drug developer uses RWE to research psychedelic therapies

  • Post author:barneyneal96
  • Post published:June 19, 2021
  • Post category:News

Continue ReadingDrug developer uses RWE to research psychedelic therapies
Read more about the article Albert Labs announces C$4M financing ahead of CSE listing

Albert Labs announces C$4M financing ahead of CSE listing

  • Post author:Olly PP
  • Post published:April 15, 2021
  • Post category:News

Continue ReadingAlbert Labs announces C$4M financing ahead of CSE listing

Recent Posts

  • Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors
  • Albert Labs Management and Board of Director Announcement
  • Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology
  • Expansion of Drug Discovery and a Promising Pipeline
  • Albert Labs Announces Private Placement

Recent Comments

  • Randal Elliott on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Nicholas Stewart on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Camille Ortega on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Kelly Lambert on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
  • Dean Phillips on Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker

Innovative mental health medicines for patients with unmet needs

  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy
  • Legal Disclaimer
  • Privacy Policy
  • Modern Slavery Statement
  • Cookie Policy

© 2024 Albert Labs. All Rights Reserved

  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
  • About
  • Clinical Trials
  • Training
  • KRN-101
  • Investing
  • Contact
Twitter Linkedin Youtube Envelope
CSE:ABRT
FSE: VB50
CSE:ABRT
FSE: VB50

About Albert Labs

We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

If you would like support or more information around making an investment, please contact [email protected]

Twitter Linkedin Youtube Envelope

Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

  • This field is for validation purposes and should be left unchanged.
Twitter
Youtube
Linkedin
Instagram
Envelope
Twitter
Youtube
Linkedin
Instagram
Envelope

Latest Press Release

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

Read more

By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok